IP Library Granted Patent US 10,461,449
Granted Patent B2
US 10,461,449 · App. 16/129,268 · Granted Oct 29, 2019

Methods for the acylation of maytansinol

Inventors: Wayne C. Widdison (Belmont, MA); Robert Yongxin Zhao (Lexington, MA)
Assignee: IMMUNOGEN, INC.
H01R12/585C07D498/16C07D498/18H05K1/0203H05K1/116H05K1/181
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,461,449
App. No.
16/129,268
Granted
Oct 29, 2019
Kind
B2
Abstract

Disclosed is a method of preparing an amino acid ester of maytansinol by reacting maytansinol with an N-carboxyanhydride of an amino acid (NCA) in the presence of a drying agent. Also disclosed is an improved method of preparing an amino acid ester of maytansinol in which a nucleophile is added to the reaction mixture after completion of the reaction between maytansinol and an N-carboxyanhydride of an amino acid.

Claims (32)

1. A method of preparing a compound represented by the following formula:

the method comprising:

a) reacting maytansinol with an N-carboxyanhydride in a reaction mixture additionally comprising diisopropylethylamine and zinc triflate, wherein the N-carboxyanhydride is represented by the following formula:

 thereby forming the compound of Formula (6a):

b) reacting unreacted N-carboxyanhydride from the reaction mixture in step a) with methanol;

c) reacting the compound of formula (6a) with a carboxylic acid having the formula R 3 COOH in the presence of a condensing agent or with an activated carboxylic acid having the formula R 3 COX, to form a compound represented by the following formula:

 wherein R 2 is methyl; R 3 is —Y—S—SR 4 ; Y is —CH 2 CH 2 — or —CH 2 CH 2 C(CH 3 ) 2 —; R 4 is —CH 3 ; —COX is N-succinimidyl ester; and

d) reacting the compound of formula (IIIa) with a reducing agent to form the compound DM1 or DM4.

2. The method of claim 1 , wherein in step c), the compound of formula (1) is reacted with a carboxylic acid having R 3 COOH in the presence of a condensing agent.

3. The method of claim 2 , wherein the condensing agent is N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC).

4. The method of claim 1 , wherein the reducing agent is dithiothreitol (DTT), (tris(2-carboxyethyl)phosphine) (TCEP) or NaBH 4 .

5. The method of claim 4 , wherein the reducing agent is dithiothreitol (DTT).

6. The method of claim 1 , wherein the reaction mixture in step a) further comprises a drying agent.

7. The method of claim 6 , wherein the drying agent is molecular sieve, sodium sulfate, calcium sulfate, calcium chloride, or magnesium sulfate.

8. The method of claim 1 , wherein the method is for preparing DM1.

9. The method of claim 1 , wherein the method is for preparing DM4.

10. A method of preparing a compound represented by the following formula:

the method comprising:

a) reacting maytansinol with an N-carboxyanhydride in a reaction mixture additionally comprising diisopropylethylamine, zinc triflate and a drying agent selected from the group consisting of a molecular sieve, sodium sulfate, calcium sulfate, calcium chloride and magnesium chloride, wherein the N-carboxyanhydride is represented by the following formula:

 thereby forming the compound of Formula (6a):

 and

b) reacting unreacted N-carboxyanhydride from the reaction mixture in step a) with a nucleophilic reagent that is water;

c) reacting the compound of formula (6a) with a carboxylic acid having the formula R 3 COOH in the presence of a condensing agent or with an activated carboxylic acid having the formula R 3 COX, to form a compound represented by the following formula:

 wherein R 2 is methyl; R 3 is —Y—S—SR 4 ; Y is —CH 2 CH 2 — or —CH 2 CH 2 C(CH 3 ) 2 − ; R 4 is —CH 3 ; —COX is N-succinimidyl ester; and

d) reacting the compound of formula (IIIa) with a reducing agent to form the compound DM1 or DM4.

11. The method of claim 10 , wherein in step c), the compound of formula (1) is reacted with a carboxylic acid having R 3 COOH in the presence of a condensing agent.

12. The method of claim 11 , wherein the condensing agent is N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC).

13. The method of claim 10 , wherein the reducing agent is dithiothreitol (DTT), (tris(2-carboxyethyl)phosphine) (TCEP) or NaBH 4 .

14. The method of claim 13 , wherein the reducing agent is dithiothreitol (DTT).

15. The method of claim 10 , wherein the drying agent is molecular sodium sulfate.

16. The method of claim 10 , wherein the method is for preparing DM1.

17. The method of claim 10 , wherein the method is for preparing DM4.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 12, 2024
From: BIOPHARMA CREDIT PLC
To: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
Reel/Frame 066553/0109 →
PATENT SECURITY AGREEMENT Recorded Apr 6, 2023
From: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 063282/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2018
From: WIDDISON, WAYNE C.; ZHAO, ROBERT YONGXIN
To: IMMUNOGEN, INC.
Reel/Frame 046993/0645 →
Continuity (6)
Continuation 15708346 · Sep 19, 2017
Continuation 15269163 · Sep 16, 2016
Continuation 14660050 · Mar 17, 2015
Continuation 14037657 · Sep 26, 2013
Provisional Application 61705731 · Sep 26, 2012
Related Publication 20190013604A1 · Jan 10, 2019